J.C. Ruffinelli

789 citations

27 papers · 271 indexed · h-index 9

Impact in

Oncology
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Geriatrics and Gerontology

Papers in ⓘ

Geriatrics and Gerontology 3
- Frailty in Older Adults 3
Oncology 18
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 4

Co-authors: Takayuki Yoshino (3 shared papers)Janet Graham (3 shared papers)Julien Taı̈eb (3 shared papers)Takeshi Kato (3 shared papers)Paul J. Ross (3 shared papers)Jean-Claude Vedovato (3 shared papers)Rona Yaeger (4 shared papers)Eric Van Cutsem (3 shared papers)
Journals: Journal of Clinical Oncology (10 papers)Annals of Oncology (5 papers)Cancers (3 papers)British Journal of Cancer (2 papers)Journal of Thoracic Oncology (2 papers)
Partner nations: Spain United States Japan

In The Last Decade

J.C. Ruffinelli

26 papers receiving 267 citations

Peers

Countries citing papers authored by J.C. Ruffinelli

Since Specialization

Citations

This map shows the geographic impact of J.C. Ruffinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Ruffinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Ruffinelli more than expected).

Fields of papers citing papers by J.C. Ruffinelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C. Ruffinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Ruffinelli. The network helps show where J.C. Ruffinelli may publish in the future.

Co-authors

The 25 scholars most cited alongside J.C. Ruffinelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.C. Ruffinelli Line = papers co-authored together J.C. Ruffinelli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF^V600E-Mutant Metastatic Colorectal Cancer Journal of Clinical Oncology ·Eric Van Cutsem, Julien Taı̈eb, Rona Yaeger, Takayuki Yoshino, Axel Grothey, Evaristo Maiello, Elena Élez, Jeroen Dekervel, Paul J. Ross, Ana Ruiz‐Casado, Janet Graham, Takeshi Kato, J.C. Ruffinelli, Thierry André, E. Carriere Roussel, Isabelle Klauck, M. Groc, Jean-Claude Vedovato, Josep Tabernero	2023	63
2	LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer Annals of Oncology ·Axel Grothey, Josep Tabernero, Julien Taı̈eb, Rona Yaeger, Takayuki Yoshino, Evaristo Maiello, E. Elez Fernandez, (unknown), Paul J. Ross, Thierry André, Takeshi Kato, J.C. Ruffinelli, Janet Graham, Marc Van den Eynde, Ruth Vera, Baptiste Niyibizi Jean, E. Carriere Roussel, C. Cahuzac, Zahida Issiakhem, Jean-Claude Vedovato, Eric Van Cutsem	2020	33
3	Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer British Journal of Cancer ·Maite Antonio, Juana Saldaña, Jenniffer Linares, J.C. Ruffinelli, Ramón Palmero, Arturo Navarro-Martín, M. Arnaiz, Isabel Brao, Samantha Aso, Susana Padrones, Valentı́ Navarro, Jesús González‐Barboteo, Josep M. Borràs, Felipe Cardenal, Ernest Nadal	2018	32
4	Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy BMC Cancer ·M.A. Bergamino, Antonio Rullan, Maria Saigí, Inmaculada Peiró, Eduard Montanya, Ramón Palmero, J.C. Ruffinelli, Arturo Navarro-Martín, M. Arnaiz, Isabel Brao, Samantha Aso, Susana Padrones, Felipe Cardenal, Ernest Nadal	2019	26
5	The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407) The Oncologist ·Enrique Grande, Àlex Teulé, Teresa Alonso‐Gordoa, Paula Jiménez‐Fonseca, Marta Benavent, Jaume Capdevila, Ana Custodio, Ruth Vera, Javier Muñarriz, Adelaida La Casta, Juan J. Díez, Pablo Gajate, Javier Molina‐Cerrillo, Ignacio Matos, Eva Cristóbal, J.C. Ruffinelli, José Palacios, Rocio García‐Carbonero	2020	24
6	O-10 ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E–mutant metastatic colorectal cancer Annals of Oncology ·Eric Van Cutsem, Julien Taı̈eb, Rona Yaeger, Takayuki Yoshino, Evaristo Maiello, Élena Elez, Jeroen Dekervel, Paul J. Ross, (unknown), Janet Graham, Takeshi Kato, J.C. Ruffinelli, Thierry André, E. Carriere Roussel, Isabelle Klauck, M. Groc, Axel Grothey, Jean-Claude Vedovato, Josep Tabernero	2021	20
7	MA06.05 CodeBreaK 101: Safety and Efficacy of Sotorasib with Carboplatin and Pemetrexed in KRAS G12C-Mutated Advanced NSCLC Journal of Thoracic Oncology ·Jeffrey Clarke, Enriqueta Felip, B.T. Li, J.C. Ruffinelli, Pilar Garrido, Jon Zugazagoitia, Sarah B. Goldberg, Suresh S. Ramalingam, Iván Victoria, Sonam Puri, David R. Gandara, T. Varrieur, Sally Edmonds, Kerry Palmer, Wendy Snyder, Ramaswamy Govindan, Igor I. Rybkin	2023	12
8	Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer Cancers ·Joaquim Bosch‐Barrera, Sara Verdura, J.C. Ruffinelli, Enric Carcereny, Èlia Sais, Elisabet Cuyàs, Ramón Palmero, Eugeni López‐Bonet, A. Hernández, Glòria Oliveras, María Buxó, Á. Izquierdo, Teresa Morán, Ernest Nadal, Javier A. Menéndez	2021	11
9	Ectopic Cushing’s syndrome due to thymic neuroendocrine tumours: a systematic review Reviews in Endocrine and Metabolic Disorders ·Fernando Guerrero‐Pérez, Inmaculada Peiró, Agustina Pia Marengo, Àlex Teulé, J.C. Ruffinelli, Roger Llatjós, Teresa Serrano, Iván Macı́a, Núria Vilarrasa, Pedro Iglesias, Carles Villabona	2021	10
10	Sotorasib plus carboplatin and pemetrexed in KRAS G12C advanced NSCLC: Updated analysis from the international CodeBreaK 101 trial. Journal of Clinical Oncology ·Bob T. Li, Jeffrey Clarke, Enriqueta Felip, J.C. Ruffinelli, Pilar Garrido, Jon Zugazagoitia, Sarah B. Goldberg, Suresh S. Ramalingam, Iván Victoria, Sonam Puri, David R. Gandara, William Kormany, Sophie Edmonds, Kerry Palmer, Ravi G. Gupta, Ramaswamy Govindan	2024	8
11	Stereotactic Body Radiotherapy versus Surgery for Lung Metastases from Colorectal Cancer: Single-Institution Results Cancers ·N. García, Ricard Ramos-Izquierdo, Valentín Navarro-Perez, Kevin Molina, M. Arnaiz, Susana Padrones, J.C. Ruffinelli, Cristina Santos, Ferrán Guedea, Arturo Navarro-Martín	2023	5
12	1320MO Early evidence of efficacy in patients (pts) with non-small cell lung cancer (NSCLC) with HER2 exon20 insertion (ex20ins) mutations treated in a phase I study with BAY 2927088 Annals of Oncology ·Herbert H. Loong, Gennaro Daniele, T-Y. Yang, Ticiana Leal, Kōichi Goto, Yuki Shinno, Kazumi Nishino, Tomohiro Sakamoto, Enriqueta Felip, J.C. Ruffinelli, Natalia Gallot, Zhou Wang, Chen Chen, Barbara J. Brennan, S-F. Pu, Martin Kornacker, Paolo Grassi, Xiuning Le, Daniel Shao-Weng Tan, B-C. Goh	2023	4
13	3D collagen migration patterns reveal a SMAD3-dependent and TGF-β1-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinoma British Journal of Cancer ·Yago Juste-Lanas, Natalia Díaz‐Valdivia, Alejandro Llorente, Rafael Ikemori, Alejandro Bernardo, Marselina Arshakyan, Carlos Borau, José Ramírez, J.C. Ruffinelli, Ernest Nadal, Noemı́ Reguart, José Manuel García‐Aznar, Jordi Alcaraz	2022	3
14	Spatial Immunology in Liver Metastases from Colorectal Carcinoma according to the Histologic Growth Pattern Cancers ·Gemma Garcia‐Vicién, Artur Mezheyeuski, Patrick Micke, Nuria Ruíz, J.C. Ruffinelli, Kristel Mils, María Bañuls, N. Martinez Molina, Ferrán Losa, Laura Lladó, David G. Mollevı́	2022	3
15	A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C-mutated colorectal cancer. Journal of Clinical Oncology ·Rona Yaeger, Corey J. Langer, J.C. Ruffinelli, Marwan Fakih, Muhammad Furqan, Jean‐Pascal Machiels, Yaneth Saportas, Jane Nolte-Hippenmeyer, Emily Chan, Caihong Xia, Toshiki Masuishi	2024	3
16	New advances in the clinical management of RAS and BRAF mutant colorectal cancer patients Expert Review of Gastroenterology & Hepatology ·J.C. Ruffinelli, C. Santos Vivas, Rebeca Sanz‐Pamplona, Vı́ctor Moreno	2020	2
17	575TiP Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914) Annals of Oncology ·Enrique Grande, Rocio García‐Carbonero, Àlex Teulé, Marta Benavent Viñuales, Paula Jiménez‐Fonseca, Javier Molina‐Cerrillo, Carlos López, Ana Custodio, Cinta Hierro, Javier Gállego, Vicente Alonso, Alberto Carmona‐Bayonas, Marta Llanos, Isabel Sevilla, Jorge Hernando, FJ Manzano Lista, B. Antón Pascual, J.C. Ruffinelli, I. Gallego Jiménez, Jaume Capdevila	2021	2
18	Prevalence of pathogenic germline variants in a cohort of patients with early onset non-small cell lung cancer (EOLUNG). Journal of Clinical Oncology ·Maria Jové, Mireia Gausachs, Joaquim Bosch‐Barrera, Enric Carcereny, Àlex Teulé, Miguel Mosteiro, Marta Pineda, Eva Tornero, Sara Hijazo‐Pechero, J.C. Ruffinelli, Jesús Brenes, A. Iván Hernández, C. Fina, Èlia Sais, Joan Brunet, Marta Doménech, Maria Saigí, Teresa Morán, Conxi Lázaro, Ernest Nadal	2023	2
19	1315P Impact of high fasting plasma glucose in the clinical outcome of patients with advanced NSCLC with PD-L1 ≥ 50% treated with frontline pembrolizumab Annals of Oncology ·S. Llop Serna, Ester Cantó Puig, Ramón Palmero, Jesús Brenes, Noelia Vilariño, J.C. Ruffinelli, Carlos Mesía Barroso, J. Saldaña Cañada, Maria Jove Casulleras, I. Brao Pérez, M. Arellano, Francesca Mateo, I. Peiró Martínez, Celia Pinedo, Ernest Nadal	2021	1
20	The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells SHILAP Revista de lepidopterología ·Gemma Garcia‐Vicién, Nuria Ruíz, Patrick Micke, J.C. Ruffinelli, Kristel Mils, María Bañuls, N. Martinez Molina, Miguel Ángel Pardo, Laura Lladó, Artur Mezheyeuski, David G. Molleví	2024	1

About J.C. Ruffinelli

J.C. Ruffinelli is a scholar working on Geriatrics and Gerontology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 27 papers that have together received 271 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Genetic factors in colorectal cancer (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Frailty in Older Adults (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Oncology (180 citations), Geriatrics and Gerontology (20 citations), Pathology and Forensic Medicine (59 citations), Pulmonary and Respiratory Medicine (102 citations) and Cancer Research (45 citations). J.C. Ruffinelli has collaborated with scholars based in Spain, United States and Japan. Frequent co-authors include Takayuki Yoshino, Janet Graham, Julien Taı̈eb, Takeshi Kato, Paul J. Ross, Jean-Claude Vedovato, Rona Yaeger, Eric Van Cutsem, Axel Grothey and Evaristo Maiello. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, British Journal of Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact